Hester Biosciences

Hester Biosciences Limited (HBL) is a publicly-traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad.[1] Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India,[2] making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains.

Hester Biosciences Limited
TypePublic
IndustryAnimal healthcare
Founded1983
FounderRajiv Gandhi
Headquarters
Ahmedabad
,
India
Area served
Worldwide
ProductsPoultry & Large Animal Vaccines
Number of employees
300
Websitewww.hester.in

Finances

Hester equity shares are listed on the National Stock Exchange of India (NSE) as HESTERBIO and on the BSE (Security Code: 524669).[3] They are also the owners of subsidiaries including Hester Biosciences Africa,[4] and have acquired other company’s like Gujarat Agrofarm (which they purchased in 2007).[5] As on 31 March 2019, market capitalisation of the company stood at Rs. 13.1 billion.[6] The CEO and founder of the company is Rajiv Gandhi.[7] For the Q1FY20 ended June 2019, Hester Biosciences registers 11% sales growth in Q1FY20; Nepal unit registers 64% revenue growth, construction of Africa unit underway.[8]

Operations

Hester creates products including vaccines, drugs, feed supplements and disinfectants.[9] They have a line of 45 poultry vaccines (live and inactivated), 4 large animal vaccines (live and inactivated), health products and diagnostics.[10] Hester also provides seromonitoring for poultry farms and mastitis prevention programmers for cattle farms.[11] The company owns and operates Asia's largest single-location animal biological manufacturing facility.[12] Hester Biosciences also has an R&D unit at Kadi,[10] and develops new animal vaccines,[7] an example of which is the Goat Pox vaccine Live-Uttarkashi strain used in India.[13] They have also partnered with Galvmed on vaccines for Newcastle disease.[14]

The Company is planning to increase its exports to the African region following good market potential and the need for animal vaccines in that region. Hester expects export revenues from Africa to increase to about 70 percent in the coming years from 40-45 percent currently. In the first nine months of the current fiscal, Hester's overall exports stood at Rs 12 crore, with Africa's share at 40-45 percent. Hester targets African market for poultry, animal healthcare products[15]

Recognition

In 2010 Hester Biosciences received "The Best Animal Vaccine Company" honor from The New Economy in the UK.[16]

See also

References
  1. "Hester Biosciences Q2 net up 48%".
  2. "Hester Company Profile". Hester.in.
  3. "NSE - National Stock Exchange of India Ltd". nseindia.com.
  4. "Hester Biosciences gets board nod to set up $3 million animal vaccine plant in Africa". Moneycontrol.
  5. "Ahmedabad-based Hester Biosciences acquires Gujarat Agrofarm". 21 November 2014.
  6. "Hester Biosciences Share Price Live, Hester Biosciences Stock Price Today". Moneycontrol.
  7. "Hester Biosciences plans to raise fresh funds for its proposed African animal vaccine plant". Moneycontrol.
  8. "Hester Biosciences registers 11% sales growth in Q1FY20". 31 July 2019.
  9. Editorial, Reuters. "${Instrument_CompanyName} ${Instrument_Ric} Company Profile - Reuters.com". U.S. {{cite web}}: |first= has generic name (help)
  10. "How Hester Biosciences became second largest poultry vaccine manufacture: CEO and MD Rajiv Gandhi explains". 30 June 2017.
  11. "Hester Biosciences Ltd, HESTERBIOOL:NSI profile - FT.com". markets.ft.com.
  12. indiainfoline.com. "Rajiv Gandhi, CEO & MD, Hester Biosciences Ltd".
  13. Reporter, S. I. (19 March 2015). "Hester Biosciences surges 10% on launching PPR and goat pox vaccine". Business Standard India – via Business Standard.
  14. "Gujarat based Hester finds mention in Bill Gates speech". 9 December 2017.
  15. "Hester targets African market for poultry, animal healthcare products".
  16. "India biosciences ready to fly". The New Economy, UK.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.